CIK 0001863127 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831476348
- Phone
- (619) 728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 72 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-04 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +997,864 | $9.63 | $9.6M | 9,695,820 |
| 2025-05-29 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +22,200 | 22,200 | ||
| 2025-05-29 | Verjee Rehan Director | Grant or award · Stock Option (Right to Buy) | +22,200 | 22,200 | ||
| 2025-05-29 | Simson Jake Director | Grant or award · Stock Option (Right to Buy) | +22,200 | 22,200 | ||
| 2025-05-29 | MORE ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +22,200 | 22,200 | ||
| 2025-05-29 | Moran Susan Director | Grant or award · Stock Option (Right to Buy) | +22,200 | 22,200 | ||
| 2025-05-29 | Rothenberg Stephen Michael Director | Grant or award · Stock Option (Right to Buy) | +22,200 | 22,200 | ||
| 2025-05-29 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +22,200 | 22,200 | ||
| 2025-03-14 | Harris Todd President and CEO | Grant or award | +1,241 | $9.78 | $12K | 1,357,168 |
| 2025-03-14 | Fuhrman Alan Chief Financial Officer | Grant or award | +1,238 | $9.78 | $12K | 14,087 |
| 2025-02-05 | Kjellson Nina S Director | Sale | −1,890 | $13.76 | $26K | 3,700,705 |
| 2025-02-05 | Kjellson Nina S Director | Sale | −3,511 | $13.76 | $48K | 443,885 |
| 2025-01-29 | Gulfo Adele M. Director | Grant or award · Common Stock (Right to Buy) | +37,200 | 37,200 | ||
| 2025-01-23 | Kjellson Nina S Director | Sale | −4,825 | $16.26 | $78K | 3,702,595 |
| 2025-01-21 | Kjellson Nina S Director | Sale | −3,993 | $16.36 | $65K | 3,707,420 |
| 2025-01-17 | Kjellson Nina S Director | Sale | −12,808 | $16.40 | $210K | 3,711,413 |
| 2025-01-17 | Kjellson Nina S Director | Sale | −461 | $16.40 | $8K | 447,396 |
| 2025-01-16 | Kjellson Nina S Director | Sale | −6,944 | $16.29 | $113K | 3,724,221 |
| 2025-01-16 | Kjellson Nina S Director | Sale | −835 | $16.29 | $14K | 447,857 |
| 2024-11-25 | Kjellson Nina S Director | Sale | −4,706 | $16.84 | $79K | 3,731,165 |
Page 4 of 9 · 170 trades